Condiciones de salud que linaza puede ayudar a apoyar.
Flaxseed's fiber content has been shown to relieve constipation and associated abdominal discomfort in clinical trials, and it has traditionally been used for abdominal pain and bloating. RCTs in type 2 diabetic patients with constipation show improvements in bowel symptoms and comfort.
Flaxseed is a rich source of the lignan SDG and other phenolic compounds with documented antioxidant activity in human and animal studies. Pilot clinical data in cystic fibrosis patients showed increased Nrf2-regulated antioxidant enzyme expression following 40 g/day flaxseed for 4 weeks.
Clinical trials have investigated flaxseed's effect on satiety and hunger with mixed but partly positive results. A systematic review of 13 RCTs found that results were inconsistent, though three studies showed a significant reduction in hunger and appetite. The high mucilage (soluble) fiber content is the primary proposed mechanism, forming a gel that slows gastric emptying.
Flaxseed is rich in ALA (plant omega-3), secoisolariciresinol diglucoside (SDG, a lignan), and soluble fiber—a triad of compounds with arterial benefits including blood pressure reduction, LDL oxidation inhibition, and anti-inflammatory vascular effects. A 6-month RCT in hypertensive patients showed flaxseed consumption reduced SBP by 10 mmHg and DBP by 7 mmHg.
Flaxseed's ALA omega-3 and lignan content have documented anti-inflammatory properties relevant to arthritis. RCTs in rheumatoid arthritis patients show mixed results: whole flaxseed (30 g/day) reduced DAS28, pain, and morning stiffness in one trial, while flaxseed oil showed limited benefit in RA compared to whole seed.
Flaxseed's ALA omega-3, lignans, and fiber collectively reduce pro-inflammatory cytokine production relevant to autoimmune pathophysiology. A comprehensive review listed autoimmune disorders among conditions where flaxseed oil benefits have been documented across clinical and preclinical studies.
Flaxseed has been shown to reduce platelet stickiness, and its ALA content may contribute to anti-thrombotic effects. RxList and peer-reviewed reviews note that flaxseed makes platelets less sticky, potentially lowering atherosclerosis and thrombosis risk.
Multiple meta-analyses of RCTs confirm flaxseed supplementation significantly lowers both systolic and diastolic blood pressure, particularly in individuals with hypertension or cardiovascular risk factors. A 2024 meta-analysis of 5 RCTs in hypertensive subjects found SBP reduced by −8.64 mmHg and DBP by −4.87 mmHg.
Multiple RCTs and meta-analyses support flaxseed's ability to reduce fasting blood glucose, postprandial glycemia, insulin, and HOMA-IR, particularly in individuals with type 2 diabetes or prediabetes. A meta-analysis of 25 RCTs found significant reductions in blood glucose and insulin resistance. Effects are stronger with whole or ground flaxseed versus oil.
Preclinical and some human epidemiological evidence suggests flaxseed and its oil may support bone mineral density via ALA omega-3 fatty acids and phytoestrogen lignans. Epidemiological studies associate higher ALA intake with better bone health in aging populations, though direct human RCT data on whole flaxseed and BMD remain limited.
Flaxseed's soluble fiber, lignans, and ALA content collectively reduce total and LDL cholesterol in multiple clinical trials. The FDA has issued a qualified health claim for ALA (from flaxseed) and coronary heart disease risk reduction. Ground flaxseed at 30–40 g/day is the effective form.
Multiple randomized controlled trials and meta-analyses confirm that flaxseed supplementation significantly reduces key chronic inflammatory biomarkers, particularly CRP and IL-6. Its anti-inflammatory activity is attributed to three main bioactive constituents: alpha-linolenic acid (ALA), lignans (primarily secoisolariciresinol diglucoside, SDG), and soluble fiber. Evidence from clinical populations includes patients with rheumatoid arthritis, metabolic syndrome, and chronic kidney disease. Results are promising but heterogeneous, and effects on TNF-α appear non-significant.
Flaxseed's bioactive compounds (ALA, SDG lignans, fiber) exert multiple favorable effects on the cardiovascular circulation, including LDL cholesterol reduction, anti-atherosclerotic effects, and platelet activity modulation. A 2018 review in the American Journal of Physiology documented antiatherogenic, antihypertensive, cholesterol-lowering, and anti-inflammatory cardiovascular actions.
ALA omega-3 from flaxseed is associated with reduced risk of cognitive decline in observational studies, and flaxseed oil prevented cognitive and motor impairment in an animal model of hepatic encephalopathy. Human RCT data specifically on cognitive outcomes with flaxseed are limited but mechanistic evidence is supportive.
Flaxseed (Linum usitatissimum) is a clinically supported source of soluble fiber (mucilage) and insoluble fiber that softens stool, increases fecal bulk, and accelerates colonic transit, making it a recognized colon-cleansing agent. Evidence from multiple clinical studies confirms its laxative efficacy. Commonly included in colon-cleanse formulas alongside psyllium.
Flaxseed contains soluble mucilage fiber (arabinoxylan, rhamnogalacturonan) acting as a bulk-forming laxative. A 2020 Chinese RCT (n=90) found flaxseed flour was more effective than lactulose, increasing defecation frequency from 2 to 7/week (p<0.001). A 2018 single-blind RCT in constipated type-2 diabetics confirmed significant constipation score improvement vs. placebo over 12 weeks.
Observational and mechanistic evidence links higher omega-3 ALA intake (from flaxseed) to reduced depression risk, and omega-3 consumption is associated with improved mood and cognitive performance in human studies. However, a trial of flaxseed oil in children with bipolar disorder found no effect on depression symptoms.
Flaxseed oil, rich in ALA omega-3, has been studied for dry eye through a prospective observational study (n=200) reporting 85% symptom relief at 2 months with oral flaxseed oil. Topical flaxseed oil artificial tears showed benefit in a randomized controlled trial. Preclinical studies confirmed topical ALA from flaxseed reduced corneal inflammation.
Linseed (flaxseed) extract Salinum® was compared to sodium carboxymethyl cellulose in a crossover study of 20 radiation-induced xerostomia patients, with both providing beneficial dry mouth symptom relief. A subsequent double-blind RCT confirmed a chamomile-linseed combination significantly improved dry mouth, thick saliva, and swallowing difficulty versus carboxymethylcellulose in 74 elderly patients.
A clinical trial found that 12 weeks of flaxseed oil supplementation significantly improved skin hydration, sensitivity, roughness, and smoothness. Clinical results of PUFA supplementation on skin barrier parameters (hydration, transepidermal water loss, roughness) are documented in peer-reviewed dermatology literature.
ALA and linoleic acid in flaxseed oil support skin barrier function and reduce inflammatory responses relevant to eczema. Clinical and mechanistic evidence links omega-3 fatty acids to reduced eczema symptom severity. Flaxseed oil has traditional and documented use for eczema.
Flaxseed is the richest known dietary source of plant lignans, predominantly secoisolariciresinol diglucoside (SDG), which gut bacteria convert to the enterolignans enterolactone and enterodiol—weak phytoestrogens that modulate estrogen metabolism. RCTs show flaxseed increases urinary 2-OHE1 concentration and the 2:16 hydroxyestrone ratio in postmenopausal women, shifting estrogen metabolism toward less genotoxic pathways.
Flaxseed's mucilage fiber acts as a prebiotic, and clinical evidence shows supplementation alters gut microbiota composition. A randomized trial demonstrated changes in 33 metagenomic bacterial species following 6 weeks of flaxseed mucilage, alongside improved insulin sensitivity.
A 2025 review in a peer-reviewed journal specifically examined dietary flaxseed's cardiometabolic benefits and role in promoting healthy aging, noting its bioactive compounds address multiple aging-related pathways including inflammation, oxidative stress, lipid metabolism, and gut microbiota.
A meta-analysis of 45 RCTs found whole flaxseed supplementation significantly reduced body weight, BMI, and waist circumference. Effect sizes are modest and most pronounced with whole/ground flaxseed versus oil, and in individuals with obesity or metabolic syndrome.
Flaxseed has substantial clinical and human trial evidence supporting its role in cardiovascular health. Its three primary bioactive constituents—alpha-linolenic acid (ALA), the lignan secoisolariciresinol diglucoside (SDG), and soluble fiber—collectively contribute to reductions in LDL cholesterol, total cholesterol, and blood pressure. Multiple systematic reviews and meta-analyses of randomized controlled trials confirm these effects, though effect sizes are modest and results show heterogeneity across studies.
Animal studies demonstrate flaxseed diet significantly reduces ventricular fibrillation during cardiac ischemia/reperfusion compared to controls. A 2018 American Journal of Physiology review specifically documented antiarrhythmic effects as part of flaxseed's cardiovascular benefits, though clinical human data on arrhythmia endpoints are limited.
Flaxseed is a rich source of the dietary lignan secoisolariciresinol diglucoside (SDG), metabolized to enterolignans with weak phytoestrogenic activity. Clinical trials for menopausal hot flashes show mixed results—smaller studies demonstrate benefit while a phase III NCCTG RCT did not confirm significant efficacy at 410 mg lignans/day.
Ground flaxseed has been studied for IBS, with evidence suggesting benefits for constipation-predominant IBS including relief of constipation, reduced bloating, and improved bowel habits. A 2004 study found ground flaxseed more effective than psyllium for IBS-C.
Flaxseed is a rich source of alpha-linolenic acid (ALA, an omega-3 fatty acid), lignans, and mucilaginous fiber with preclinical evidence for reducing intestinal inflammation in IBD models. It modulates gut microbiota and provides SCFAs relevant to mucosal healing in IBD.
Meta-analyses of RCTs demonstrate flaxseed supplementation significantly improves insulin sensitivity markers (HOMA-IR, QUIKI index, fasting insulin). Effects are strongest with whole or ground flaxseed and in populations with type 2 diabetes, prediabetes, or metabolic syndrome.
ALA omega-3 from flaxseed is associated with neuroprotection and reduced cognitive decline in observational studies. Animal research with flaxseed oil specifically showed prevention of short-term memory and visuospatial memory impairment in a hyperammonemia model, with preserved prefrontal cortex neuronal morphology.
Flaxseed is a rich source of plant lignans converted by gut bacteria to phytoestrogenic enterolactone and enterodiol. Mixed but increasingly positive clinical trial data support its use for mild menopausal symptoms. A 2024 study found flaxseed effective for hot flashes, night sweats, and sleep difficulties.
Multiple randomized controlled trials and systematic reviews demonstrate that flaxseed supplementation meaningfully improves several components of metabolic syndrome, including elevated triglycerides, insulin resistance, blood pressure, and central obesity. Whole or ground flaxseed (typically 30 g/day) consistently outperforms lifestyle modification alone across these markers. The evidence base is clinical, not merely traditional, though study sizes remain modest and heterogeneity across trials is high.
Flaxseed is the richest dietary source of the plant lignan secoisolariciresinol diglucoside (SDG), which is metabolized to bone-protective phytoestrogens (enterolactone, enterodiol). Small clinical studies show flaxseed supplementation (40 g/day) reduces bone resorption markers in postmenopausal women. Flaxseed also provides alpha-linolenic acid (ALA), the plant n-3 PUFA with emerging bone health evidence.
Flaxseed is rich in dietary fiber, phytoestrogens (lignans), and alpha-linolenic acid (ALA). Reviews confirm flaxseed has potential to improve metabolic, anthropometric, and hormonal parameters in PCOS. Clinical evidence includes improvements in insulin resistance and androgen levels.
Flaxseed is the richest dietary source of lignans (secoisolariciresinol diglucoside, SDG), which are converted by gut microbiota to enterodiol and enterolactone—phytoestrogens that bind estrogen receptors. A 2024 single-blind RCT specifically in perimenopausal women found significant increases in lignan metabolites and improvements in perimenopausal symptoms.
Flaxseed is rich in lignans (secoisolariciresinol diglucoside) that are converted by gut bacteria to enterolactone and enterodiol, which have anti-androgenic and anti-estrogenic properties relevant to prostate health. Whole flaxseed and flaxseed oil are commonly recommended in both Europe and the US as treatments for prostate disease, though clinical evidence is limited. The phytotherapeutic RCT systematic review includes flaxseed/linseed among examined agents for biochemically recurrent prostate cancer.
Clinical trials specifically in RA patients show that whole flaxseed (30 g/day) can reduce disease activity scores, pain, and morning stiffness. Flaxseed oil (3 g/day) in one RCT outperformed fish oil for RA symptom reduction. Evidence for flaxseed oil alone is limited per institutional reviews.
A clinical trial of 12-week flaxseed oil supplementation demonstrated significant improvements in skin hydration, elasticity, and skin barrier parameters (roughness, scaling, sensitivity), all relevant to skin aging. In vivo studies in skin models showed significant improvements in hydration, sebum regulation, and visible signs of skin aging.
Flaxseed supplementation has been shown in multiple meta-analyses of RCTs to significantly reduce serum triglycerides. Its active components include ALA, lignans, and soluble fiber, each contributing to lipid-lowering effects. Whole flaxseed shows greater TG-lowering than flaxseed oil.
Flaxseed oil (rich in alpha-linolenic acid, an omega-3 fatty acid) is used in topical massage specifically for bunion pain reduction. Podiatric sources recommend lavender-infused flaxseed oil massage as a natural bunion remedy, with the omega-3 fatty acids providing anti-inflammatory benefits. Flaxseed's ALA is a plant-based precursor to EPA and DHA with systemic anti-inflammatory properties.
Flaxseed has documented traditional use for skin inflammation including dermatitis, referenced in historical medical texts and pharmacopeial traditions. RxList documents topical flaxseed application for 'eczema' and 'inflammation,' while modern evidence on ALA's anti-inflammatory skin properties provides mechanistic support.
Flaxseed's high fiber content is mechanistically relevant to diverticular health, as dietary fiber reduces intraluminal pressure and constipation, the primary contributors to diverticulosis development. Traditional use and fiber pharmacology support this, though dedicated flaxseed RCTs in diverticular disease are lacking.
Flaxseed is a rich source of alpha-linolenic acid (omega-3) and lignans, both of which have been associated with hair health. Lignans in flaxseed (secoisolariciresinol diglucoside) can be converted by gut bacteria to enterolactone, a weak phytoestrogen that may modulate androgen activity relevant to androgenetic alopecia. Flaxseed is traditionally used in hair formulations.
Flaxseed is listed among alternative therapies used for BPH in authoritative phytotherapy literature reviews, alongside lycopene, zinc, selenium, and rye pollen. Flaxseed lignans (SDG converted by gut bacteria to enterolactone) may modulate estrogen receptor signaling at the prostate, and ALA provides anti-inflammatory effects. Small clinical studies suggest flaxseed lignans may reduce PSA progression and prostate cell proliferation, though large dedicated BPH/urinary flow RCTs are lacking.
Flaxseed oil's anti-inflammatory omega-3 ALA content may reduce the immune-driven skin inflammation characteristic of psoriasis. Clinical evidence is indirect, with one 12-week human trial showing improved skin roughness, scaling, and hydration, though participants were healthy volunteers rather than psoriasis patients.
Flaxseed has documented traditional use for urinary tract conditions, including urinary tract infection and related complaints. A 2023 European Journal of Medical Research review confirms traditional use of linseed for urinary tract infection historically.
Flaxseed is a rich source of both soluble and insoluble fiber (mucilage and lignan-rich hull) used in whole-body cleanse protocols as a bowel regularity agent and toxin binder. Its mucilaginous fiber supports intestinal transit, binds bile acids and waste products for fecal excretion, and is included as a foundational fiber element in colon cleanse formulations.
Volver